Condition: Malignant Neoplasms of Digestive Organs · Sponsor: LaNova Medicines Zhejiang Co., Ltd.
This study is to evaluate the efficacy of the LM-302 Combination With Other Therapies in patients with CLDN18.2-positive Advanced Digestive Tract Tumor.
This description comes directly from the study's public registry record.
Alex Yuan · 021-68889618 · AlexYuan@Lanovamed.com
Paul Kong · 021-68889618 · paulkong@lanovamed.com
Always discuss trial participation with your own doctor first.
| Shanghai East Hospital | Shanghai, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05934331